|
（単位：%）
|
1Q21
|
2Q21
|
3Q21
|
4Q21
|
2Q22
|
2Q22
|
3Q22
|
4Q22
|
1Q23
|
2Q23
|
3Q23
|
4Q23
|
1Q24
|
2Q24
|
3Q24
|
4Q24
|
1Q25
|
2Q25
|
3Q25
|
4Q25
|
|
売上高
|
1,113
|
1,951
|
1,743
|
1,612
|
1,397
|
2,020
|
1,493
|
1,107
|
957
|
1,494
|
1,337
|
1,096
|
1,054
|
1,700
|
1,494
|
1,380
|
1,356
|
2,059
|
1,846
|
1,699
|
|
売上成長率（％）
|
-
|
-
|
-
|
-
|
|
|
|
|
-
|
|
|
|
|
|
|
25.9
|
28.7
|
21.1
|
23.6
|
23.1
|
|
研究開発費
|
96
|
73
|
89
|
105
|
108
|
107
|
81
|
63
|
48
|
45
|
45
|
44
|
47
|
47
|
47
|
46
|
49
|
63
|
67
|
65
|
|
営業費用
|
1,326
|
1,959
|
1,844
|
1,784
|
1,582
|
2,119
|
1,645
|
1,260
|
1,105
|
1,538
|
1,376
|
1,179
|
1,186
|
1,679
|
1,497
|
1,421
|
1,409
|
2,020
|
1,853
|
1,741
|
|
営業利益
|
-213
|
-8
|
-101
|
-173
|
-186
|
-100
|
-152
|
-153
|
-149
|
-45
|
-39
|
-83
|
-133
|
21
|
-4
|
-41
|
-54
|
39
|
-8
|
-42
|
|
営業利益率 (%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-2.9
|
-4.0
|
1.9
|
-0.4
|
-2.5
|
|
経常（税引前）利益
|
-214
|
-9
|
-102
|
-173
|
-187
|
-100
|
-152
|
-153
|
-149
|
-47
|
-40
|
-83
|
-133
|
21
|
-3
|
-41
|
-55
|
37
|
-8
|
-42
|
|
経常（税引前）利益率（％）
|
-19.1
|
-0.4
|
-5.8
|
-10.7
|
-13.3
|
-4.9
|
-10.1
|
-13.8
|
-15.5
|
-3.1
|
-2.9
|
-7.6
|
-12.6
|
1.2
|
-0.2
|
-2.9
|
-4.1
|
1.8
|
-0.4
|
-2.5
|
|
法人税等合計
|
-1
|
-2
|
-2
|
0
|
0
|
-2
|
0
|
0
|
-
|
-
|
-1
|
0
|
-1
|
-1
|
-1
|
0
|
-4
|
0
|
-1
|
2
|
|
実効税率（％）
|
|
|
|
|
|
|
|
|
-
|
-
|
|
|
|
|
|
-0.5
|
6.2
|
0.8
|
2.6
|
-5.3
|
|
純利益
|
-213
|
-8
|
-100
|
-175
|
-188
|
-102
|
-155
|
-158
|
-151
|
-47
|
-40
|
-84
|
-133
|
20
|
-2
|
-41
|
-51
|
39
|
-5
|
-43
|
|
純利益率（％）
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-2.9
|
-3.7
|
1.9
|
-0.2
|
-2.5
|
|
一株あたり利益
|
-
|
-
|
-
|
-
|
-0.45
|
-0.24
|
-0.36
|
-0.36
|
-0.33
|
-0.1
|
-0.08
|
-0.17
|
-0.27
|
0.04
|
0
|
-0.08
|
-0.09
|
0.07
|
-0.01
|
-0.07
|
|
希薄化後一株あたり利益
|
-
|
-
|
-
|
-
|
-0.45
|
-0.24
|
-0.36
|
-0.36
|
-0.33
|
-0.1
|
-0.08
|
-0.17
|
-0.27
|
0.04
|
0
|
-0.08
|
-0.09
|
0.07
|
-0.01
|
-0.07
|
|
EBITDA
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
-21
|
-25
|
68
|
20
|
-15
|
|
EBITDAマージン（％）
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
-1.5
|
-1.8
|
3.3
|
1.1
|
-0.9
|